Conexeu Sciences Inc. (CNXU)

Conexeu Sciences Balance Sheet

Financials in millions USD. Fiscal year is November - October.

Year Ending	Oct 31, 2025	Oct 31, 2024
Cash & Equivalents	4.83	0.31
Cash & Cash Equivalents	4.83	0.31
Cash Growth	1436.51%	-
Other Current Assets	2.62	0.03
Total Current Assets	7.46	0.35
Property, Plant & Equipment	0.01	-
Goodwill and Intangibles	0.18	0.19
Other Long-Term Assets	0.04	0
Total Long-Term Assets	0.23	0.19
Total Assets	7.69	0.53
Accounts Payable	0.26	0.33
Current Debt	0	0.01
Other Current Liabilities	0.08	0
Total Current Liabilities	0.34	0.34
Long-Term Debt	-	0.1
Total Long-Term Liabilities	0	0.1
Total Liabilities	0.34	0.44
Total Debt	0	0.11
Debt Growth	-96.49%	-
Retained Earnings	-4.52	-0.6
Shareholders' Equity	7.35	0.09
Net Cash (Debt)	4.83	0.21
Net Cash (Debt) Growth	2215.77%	-
Working Capital	7.12	0.01

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).